Circulating TGF-β1 levels in patients before and on treatment with thrombopoietic agents. Plasma levels of TGF-β1 were significantly increased in patients on treatment (■) compared with before treatment (●, P = .002, using the rank order Mann-Whitney test). As comparison, levels of TGF-β1 in normal healthy controls are shown (♦).